Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bernardo

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Immigrant and Minority Health|May 2, 2022
Factors Associated with Development of Tuberculosis Disease Among Refugees, Massachusetts, 2008-2018Laura Smock, Thinh Nguyen, Kavita Gadani, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 2006
Predicting non-completion of treatment for latent tuberculous infection: a prospective surveyFred K Shieh, Graham Snyder, C Robert Horsburgh, et al.
Journal of Leukocyte Biology|June 7, 2005
Simultaneous measurements of cytoplasmic Ca2+ responses and intracellular pH in neutrophils of localized aggressive periodontitis (LAP) patientsJens Martin Herrmann, Alpdogan Kantarci, Heidi Long, et al.
Open Forum Infectious Diseases|August 29, 2020
Increasing Drug Resistance Among Persons With Tuberculosis in Massachusetts, 2009-2018Jared J Eddy, Kavita M Gadani, Andrew Tibbs, et al.
Journal of Primary Care & Community Health|August 24, 2022
Expanding Latent Tuberculosis Infection Testing and Treatment in Massachusetts Primary Care Clinics via the ECHO ModelDaria Szkwarko, Michael E Urbanowski, Rebecca Thal, et al.
Infection and Immunity|May 29, 2007
Sequential chemotactic and phagocytic activation of human polymorphonuclear neutrophilsJens Martin Herrmann, John Bernardo, Heidi J Long, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2004
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trialRobert M Jasmer, David C Snyder, Jussi J Saukkonen, et al.
Annals of Internal Medicine|October 16, 2002
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trialRobert M Jasmer, Jussi J Saukkonen, Henry M Blumberg, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2017
A Comparative Analysis of Pulmonary and Critical Care Medicine Guideline Development MethodologiesNoah C Schoenberg, Alan F Barker, John Bernardo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2013
The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United StatesSuzanne M Marks, Wendy Cronin, Thara Venkatappa, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Immigrant and Minority Health|May 2, 2022
Factors Associated with Development of Tuberculosis Disease Among Refugees, Massachusetts, 2008-2018Laura Smock, Thinh Nguyen, Kavita Gadani, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 2006
Predicting non-completion of treatment for latent tuberculous infection: a prospective surveyFred K Shieh, Graham Snyder, C Robert Horsburgh, et al.
Journal of Leukocyte Biology|June 7, 2005
Simultaneous measurements of cytoplasmic Ca2+ responses and intracellular pH in neutrophils of localized aggressive periodontitis (LAP) patientsJens Martin Herrmann, Alpdogan Kantarci, Heidi Long, et al.
Open Forum Infectious Diseases|August 29, 2020
Increasing Drug Resistance Among Persons With Tuberculosis in Massachusetts, 2009-2018Jared J Eddy, Kavita M Gadani, Andrew Tibbs, et al.
Journal of Primary Care & Community Health|August 24, 2022
Expanding Latent Tuberculosis Infection Testing and Treatment in Massachusetts Primary Care Clinics via the ECHO ModelDaria Szkwarko, Michael E Urbanowski, Rebecca Thal, et al.
Infection and Immunity|May 29, 2007
Sequential chemotactic and phagocytic activation of human polymorphonuclear neutrophilsJens Martin Herrmann, John Bernardo, Heidi J Long, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2004
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trialRobert M Jasmer, David C Snyder, Jussi J Saukkonen, et al.
Annals of Internal Medicine|October 16, 2002
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trialRobert M Jasmer, Jussi J Saukkonen, Henry M Blumberg, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2017
A Comparative Analysis of Pulmonary and Critical Care Medicine Guideline Development MethodologiesNoah C Schoenberg, Alan F Barker, John Bernardo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2013
The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United StatesSuzanne M Marks, Wendy Cronin, Thara Venkatappa, et al.
Pageof 3